Clinical trials: Hair Diseases
Cartilage-hair Hypoplasia
Immunodeficiency in Cartilage-hair Hypoplasia: Sub-project on Safety of Vaccination Against Chickenpox
The investigatoris will carefully select cartilage-hair hypoplasia patients unexposed to varicella (VZV) and immunize patients in a controlled manner with VZV vaccine.
- Trial name
- NCT02383797
- Testing
- Varilrix
- Volunteers
- 5 people
- Sponsor
- Helsinki University Central Hospital
Alopecia Areata
Efficacy of Oral Apremilast in the Treatment of Alopecia Areata at the Tertiary Care Hospital, Karachi.
Alopecia areata (AA) is a disease characterized by hair cycle dysfunction and the presence of peribulbar and perifollicular mononuclear cell infiltrate.1 The majority of patients report the rapid onset of one or several…
- Trial name
- NCT05926882
- Testing
- Apremilast 30mg
- Where
- Pakistan
- Volunteers
- 30 people, healthy volunteers welcome
- Sponsor
- Jinnah Postgraduate Medical Centre
Androgenetic Alopecia (AGA)
To Evaluate Efficacy and Safety of TopicalKX-826 Solution in Chinese Male Patients With Androgenetic Alopecia
This study is a multicenter, randomized, double-blind, vehicle controlled, adaptive design phase 2/3 study to evaluate the efficacy and safety of topical KX-826 solution in Chinese male patients with androgenetic alopecia (AGA).
- Trial name
- NCT06622824
- Testing
- KX-826 0.5% BID, KX-826 1.0% BID
- Where
- China
- Volunteers
- 756 people
- Sponsor
- Suzhou Kintor Pharmaceutical Inc,
Androgenetic Alopecia, Male Pattern Baldness
A Study to Evaluate and Compare Injections of Autologous Mixed Population of Dermal Cells Into the Balding Scalp of Subjects With Hair Loss (CA-0005995)
Evaluate the ability of injections of Ji Gami(TM) CN to induce hair growth in male and female subjects with hair loss.
- Conditions
- Androgenetic Alopecia, Male Pattern Baldness, Female Pattern Baldness
- Trial name
- NCT01451190
- Testing
- Autologous cultured dermal and epidermal cells
- Where
- 9 sites in United States
- Volunteers
- 88 people, healthy volunteers welcome
- Sponsor
- Aderans Research Institute
Alopecia Areata
Quantification of the Socio-economic Multifacet Burden of Alopecia Areata and Identification of the Associated Factors
Alopecia areata (AA) is a complex autoimmune disorder with an estimated lifetime risk of 1.7% where both genetic pre-disposition and environmental factors contribute.
- Trial name
- PelBurd (NCT05588310)
- Where
- France
- Volunteers
- 150 people
- Sponsor
- University Hospital, Toulouse
Hair Loss/Baldness
Effect of PRP on the Therapy for Hair Growth
The purpose of study is to examine the advantage of PRP on hair loss and male pattern baldness. The investigators will inject PRP into the scalp regions where with little or no hair, and evaluate the effect and efficiency of PRP…
- Trial name
- NCT02087319
- Testing
- hair loss, baldness (patient's own platelet-rich plasma)
- Where
- Taiwan
- Volunteers
- 10 people
- Sponsor
- China Medical University Hospital
HIV/AIDS
ENLIGHTEN: Establishing Novel Antiretroviral (ARV) Imaging for Hair to Elucidate Non-Adherence
Purpose: Perform a 3-phase (single dose, multi dose, dose proportionality) study in healthy volunteers using daily tenofovir+emtricitabine, dolutegravir, and maraviroc dosing to quantify intra- and inter-subject variability and…
- Trial name
- ENLIGHTEN (NCT03218592)
- Testing
- Maraviroc Pill, Dolutegravir Pill, Truvada Pill
- Where
- United States
- Volunteers
- 36 people, healthy volunteers welcome
- Sponsor
- University of North Carolina, Chapel Hill
Alopecia
AVODART® Alopecia Post-marketing Surveillance (PMS)
Post-marketing surveillance(PMS) to monitor the safety and effectiveness of dutasteride in Korean androgenetic alopecia patients
- Trial name
- AVODART®PMS (NCT01004809)
- Testing
- Dutasteride
- Where
- South Korea
- Volunteers
- 712 people
- Sponsor
- GlaxoSmithKline
Androgenetic Alopecia
Safety, Pharmacokinetics and Efficacy of PP405 in Adults With AGA
The study is a two part study, designed to validate safety results from the Phase 1 PP405-001 trial while also characterizing longer term safety and PK.
- Trial name
- NCT06393452
- Testing
- PP405 0.05% Topical Gel, Topical Vehicle Gel
- Where
- 8 sites in United States
- Volunteers
- 78 people, healthy volunteers welcome
- Sponsor
- Pelage Pharmaceuticals, Inc.
Alopecia Areata
Evaluation of Serum Levels of Interlukin-15 and Interlukin-21 in Patients With Alopecia Areata
Alopecia areata (AA) is a type of non-cicatricial alopecia. The most common presentation of AA is localized patches of hair loss on the scalp.
- Trial name
- NCT05910138
- Testing
- Serum Interlukin-15, Serum Interlukin-21
- Where
- Egypt
- Volunteers
- 90 people
- Sponsor
- Sohag University
Androgenetic Alopecia, Male Pattern Baldness
A Study to Evaluate and Compare Injections of Autologous Dermal and Epidermal Cells Into the Balding Scalp of Subjects With Hair Loss
Evaluate the ability of injections of Ji Gami(TM) and Ji Gami(TM) DO to induce hair growth in male and female subjects with hair loss.
- Conditions
- Androgenetic Alopecia, Male Pattern Baldness, Female Pattern Baldness
- Trial name
- NCT01451021
- Testing
- Autologous cultured dermal and epidermal cells
- Where
- 3 sites in United States
- Volunteers
- 21 people, healthy volunteers welcome
- Sponsor
- Aderans Research Institute
Trichotillomania (Hair-Pulling Disorder), Trichotillomania
Semaglutide (Wegovy) Treatment for Trichotillomania
This research study is testing the effectiveness and safety of semaglutide (Wegovy) in people with trichotillomania, also known as hair-pulling disorder.
- Conditions
- Trichotillomania (Hair-Pulling Disorder), Trichotillomania, Hair Pulling Disorder, Hair Pulling
- Trial name
- NCT07282769
- Testing
- Semaglutide
- Volunteers
- 10 people
- Sponsor
- University of Chicago
Alopecia Areata
Evaluation of the Efficacy of Systemic Treatments for Alopecia (ESTAA)
The aim of our study was to retrospectively assess the efficacy and safety of systemic treatments in patients with alopecia areata, by recruiting cases from the HUGO network (Hôpitaux Universitaires du Grand Ouest), a network of…
- Trial name
- ESTAA (NCT06471114)
- Where
- France
- Volunteers
- 250 people
- Sponsor
- University Hospital, Brest
Alopecia Areata
A Study of KL130008 in Adults With Severe Alopecia Areata
The purpose of this study is to assess KL130008 is safe and effective in adults with severe alopecia areata
- Trial name
- NCT05496426
- Where
- China
- Volunteers
- 114 people
- Sponsor
- Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.
Androgenetic Alopecia, Androgenetic Alopecia (AGA)
Phase 3 Study to Evaluate the Efficacy and Safety of Oral Minoxidil (N1087) in Men With Androgenetic Alopecia.
This study is a Phase 3 clinical trial designed to evaluate the efficacy and safety of N1087 compared with placebo in adult men with androgenetic alopecia (male pattern hair loss).
- Trial name
- MINORA-MEN (NCT07529977)
- Testing
- Minoxidil oral solution
- Volunteers
- 372 people
- Sponsor
- Eurofarma Laboratorios S.A.
Hypertrichosis, Alopecia
Investigation of FOL-005 on Clinical Safety and Effect on Hair Growth
A study to investigate clinical safety and effect on hair growth of FOL-005 in healthy volunteers. The study is divided in two parts, a single ascending dose (SAD) part and a multiple dose (MD) part.
- Conditions
- Hypertrichosis, Alopecia, Hirsutism
- Trial name
- NCT02793557
- Testing
- FOL-005
- Where
- Germany
- Volunteers
- 44 people, healthy volunteers welcome
- Sponsor
- Follicum AB
Trichotillomania
Cognitive Behavioral Group Therapy for Trichotillomania (Hair Pulling Disorder)
This study aims at evaluating the effectiveness of group-based cognitive behavioral therapy for trichotillomania at three clinical sites in Norway.
- Trial name
- NorTriP (NCT02747771)
- Testing
- Cognitive behavioral therapy
- Where
- Norway
- Volunteers
- 150 people
- Sponsor
- Oslo University Hospital
Alopecia, Alopecia, Androgenetic
A Safety and Efficacy Study of Bimatoprost in Men With Androgenic Alopecia (AGA)
This is a safety and efficacy study of bimatoprost in male subjects with androgenic alopecia (AGA).
- Conditions
- Alopecia, Alopecia, Androgenetic, Baldness
- Trial name
- NCT01904721
- Testing
- Bimatoprost Solution 1, Bimatoprost Solution 2, Bimatoprost Vehicle
- Where
- United States
- Volunteers
- 244 people
- Sponsor
- Allergan
Androgenic Alopecia
Effectiveness of Apheresis Platelet-Rich Plasma Injection for Androgenic Alopecia
This study was retrospectively registered. The goal of this single-arm, single-center, prospective clinical trial is to evaluate the effectiveness and safety of autologous apheresis platelet-rich plasma (PRP) injection in the…
- Trial name
- PRP-AGA (NCT07348315)
- Testing
- Autologous Apheresis PRP Injection
- Where
- China
- Volunteers
- 201 people
- Sponsor
- zhang li
Keloid, Scleroderma, Localized
Ultraviolet B (UVB) Light Therapy in the Treatment of Skin Conditions With Altered Dermal Matrix
This research study will evaluate the effectiveness of high dose UVB light therapy in the treatment of keloid (or hypertrophic scar), scleroderma, acne keloidalis nuchae, old burn scars, granuloma annulare or related conditions.
- Conditions
- Keloid, Scleroderma, Localized, Acne Keloidalis, Scars
- Trial name
- NCT00129428
- Testing
- UVB Irradiation
- Where
- United States
- Volunteers
- 33 people
- Sponsor
- University of Michigan